Skip to main content
Technology in Cancer Research & Treatment logoLink to Technology in Cancer Research & Treatment
. 2020 Nov 15;19:1533033820973812. doi: 10.1177/1533033820973812

Corrigendum to “Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis”

PMCID: PMC7675895  PMID: 33191876

Chen G, Zhu L, Yang Y, et al. Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis. Technology in Cancer Research & Treatment. 2018;17: 1-8. Original DOI: doi.org/10.1177/1533033818791500

In the above referenced article the authors have re-evaluated the pooled HRs and found that the conclusions were unchanged (OS: HR=1.64, 95% CI=1.41 -1.90, p=0.000; PFS: HR=1.61, 95% CI=1.42 -1.83, p=0.000). The forest plots have been corrected.

Figure 2.

Figure 2.

Forest plots of studies evaluating HR with 95% CI of NLR for OS in subgroup analysis by ethnicity. The center of each square represents the HR, the area of the square is the number of sample and thus the weight used in the meta-analysis, and the horizontal line indicates the 95% CI. CI indicates confidence interval; HR, hazard ratio; NLR, neutrophil to lymphocyte ratio; OS, overall survival.

Figure 3.

Figure 3.

Forest plots of studies evaluating HR with 95% CI of NLR for PFS in subgroup analysis by ethnicity. The center of each square represents the HR, the area of the square is the number of sample and thus the weight used in the meta-analysis, and the horizontal line indicates the 95% CI. CI indicates confidence interval; HR, hazard ratio; NLR, neutrophil to lymphocyte ratio; PFS, progression-free survival.

Also, the author would like to give credit to the people that have written pointing out the mistake that resulted in the corrigendum. Their names are and their affiliations and contact information are below:

Si Li, Kunming Medical University, Kunming, Yunnan, China 2276375647@qq.com

Xinrui Lin, Kunming Medical University, Kunming, Yunnan, China 544861582@qq.com

The online version of the paper has also been corrected.


Articles from Technology in Cancer Research & Treatment are provided here courtesy of SAGE Publications

RESOURCES